Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

This week’s research roundup features a study on how ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.

Today's topic includes: Delta variant outbreaks around the world, long COVID afflicting children, is it recommended to get the Pfizer booster after receiving J&J vaccine, vaccine clinical trials, and does vaping make you more susceptible to COVID-19?

The following list includes updates posted to mayocliniclabs.com during the month of June.

Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., discuss how to prevent, diagnose, and treat vector-borne diseases — illness you get from blood-feeding anthropods like ticks and mosquitos — that are more common during the summertime.

This week’s research roundup features a study on MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.

Pua Hopson, D.O., discusses Mayo Clinic Labs’ new disaccharidase activity panel, which measures levels of five digestive enzymes to identify deficiencies that cause carbohydrate maldigestion and can lead to chronic conditions like celiac disease or inflammatory bowel disease. Performed on tissue sample biopsies during upper endoscopy, the activity panel is the gold standard test for detecting disaccharidase deficiencies.

Today's Topics Include: Nearly all COVID deaths are related to the unvaccinated, COVID still being a greater risk to teens than the vaccine, Olympic rules in Tokyo, Mayo Clinic guidance on summer travel, Mayo receives award for recovery after surgery project, and Mayo Q&A on helping COVID long- haulers get back on their feet.

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D. discuss a recent report to Congress that outlined potential laboratory fee reimbursement changes, and what that could mean for labs going forward.

This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.

Divyanshu (Div) Dubey, M.B.B.S., explains how Mayo Clinic Labs’ new Kelch-11 antibody test — the first in the world — can confirm diagnosis, guide treatment, and improve outcomes in patients affected by testicular cancer-associated paraneoplastic encephalitis.

Top stories include: COVID-19 travel tips for people with weakened immune systems, Mayo clinic Q&A on examining reports of heart inflammation in young people after second COVID-19 vaccine, and what Mayo Clinic has to offer with COVID-19 walk in vaccine clinics in Minnesota.